Cardinal Health stock: UBS raises target from USD 280.00 to USD 295.00
Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash
UBS raised its Cardinal Health price target to USD 295.00 from USD 280.00, keeping a Buy rating. The new target implies a 16.05% premium to the NYSE price, with the stock near its 52-week high. Cardinal Health posted a 14.21% revenue increase in fiscal 2026 to USD 254.25 billion.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.